Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
712
datasets available to search
ShareScore release 0.9.0
Dataset results
712 results for “mantle”
Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00334438. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05910801. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01410513. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL)
ClinicalTrials.gov study NCT04127916. IPD Sharing: NO. Countries: 1. Publications: 0.
ZSDT for the Treatment of R/R Mantle Cell Lymphoma After BTK Inhibitor Failure: a Multi-center Prospective Clinical Trial
ClinicalTrials.gov study NCT07264894. IPD Sharing: NO. Countries: 1. Publications: 0.
Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01578343. IPD Sharing: YES. Countries: 1. Publications: 0.
Patient-Derived Xenografts in Personalizing Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03219047. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
ClinicalTrials.gov study NCT07003295. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01345357. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients.
ClinicalTrials.gov study NCT05249959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT01926665. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04939272. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05861050. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00003039. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mantle Irradiation for Hodgkin's Disease
ClinicalTrials.gov study NCT00165269. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy
ClinicalTrials.gov study NCT00727207. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL)
ClinicalTrials.gov study NCT01221103. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab Maintenance Therapy in Aggressive CD20 (Cluster of Differentiation Antigen 20) Positive Lymphoma and Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01933711. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05635162. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Lenalidomide Observational Study in Patients With Mantle Lymphoma in Relapse/Refraction. Spanish Programme RRMCL Results.
ClinicalTrials.gov study NCT04109872. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.